Liminatus Pharma LIMN
NASDAQ LIMN
$3.84 -0.07 (-1.79%)
As of: Sep 30, 2026 · 12:18 PM EDT

Liminatus Pharma (LIMN) Enterprise Value (2025 - 2026)

Updated

Liminatus Pharma (LIMN) posted Enterprise Value of $3.14 million for Q2 2026, down 99.0% from $300.43 million a year earlier and down 26.7% from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Enterprise Value (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Enterprise Value at Liminatus Pharma was $169,955, down 99.9% year-over-year; for FY2025, it was $16.17 million.

  • According to Business Quant data, Enterprise Value for the three prior quarters was $4.28 million (Q1 2026), $16.17 million (Q4 2025) and $44.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Liminatus Pharma 4.78 Mn 4.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.14 Mn
Mar 31, 2026 4.28 Mn
Dec 31, 2025 16.17 Mn
Sep 30, 2025 44.47 Mn
Jun 30, 2025 300.43 Mn
API Access

Liminatus Pharma Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=LIMN&period=max&api_key=YOUR_API_KEY